Fava Bean Protein Patent Landscape
Identifiers
Which organizations and claims shape current development around fava bean protein?
Roquette Freres and Corn Products Development Inc. are the key organizations. Roquette Freres holds two patents (WO2026104658A1, EP4744495A1) claiming non-dairy fermented foods with fava protein isolate, specifying protein content, pH, and firmness ratios. They also list eight probiotic strains as co-ingredients, indicating a focus on synbiotic formulations. Corn Products Development Inc. holds JP7651538B2 claiming a heat-moisture processed fava protein concentrate with specific protein content (50–73%), denaturation enthalpy (5.5–7.0 J/g), and particle size distributions. These claims are technical and functional, not regulatory or safety-related. The assignees are large ingredient suppliers, suggesting industrial-scale interest.
How is Fava bean protein innovation changing in Food & Beverage?
Monthly patent filings by domain
Which technical problems do recent patents address with fava bean protein?
Recent patents address the technical problem of achieving adequate texture and structure in non-dairy fermented products using fava bean protein as the primary protein source. Specifically, Roquette Freres claims a non-dairy fermented food with a firmness-to-protein ratio above 10, preferably above 15, at a pH of 3.80–4.40, indicating a focus on gelation and water-holding capacity. Corn Products Development Inc. addresses thermal stability and particle size control by heat-moisture processing fava bean protein concentrate, reducing denaturation enthalpy by 10–30% and increasing particle diameters, which likely improves dispersibility and mouthfeel. These are formulation challenges, not regulatory or safety issues.
How do recent patents change the role or application of fava bean protein?
Recent patents shift fava bean protein from a supplemental ingredient to a primary structural protein in non-dairy fermented foods. Roquette Freres claims fava protein isolate as the main protein source, with total protein content of 2.5–12.0 g/100g, and emphasizes its role in providing firmness and texture comparable to dairy. This is a significant change from traditional uses as a flour or concentrate. Corn Products Development Inc. positions heat-moisture processed fava protein concentrate (50–73% protein) as a primary component in general foods, suggesting a move toward higher-protein, cleaner-label formulations. The role is now functional—texture, structure, and protein delivery—rather than just a protein extender.
How is Fava bean protein used in Food & Beverage patents?
Which Food & Beverage product categories feature Fava bean protein in recent patents?
Which product categories and formulation strategies emerge in recent work on fava bean protein?
Emerging strategies center on non-dairy fermented products (e.g., yogurt alternatives) and heat-moisture processed protein concentrates. Roquette Freres combines fava protein isolate with probiotic strains (Bifidobacterium, Lactobacillus, Streptococcus, Weissella) to create a fermented product with controlled pH (3.80–4.40) and high firmness-to-protein ratio. This suggests a strategy to mimic dairy texture while adding probiotic benefits. Corn Products Development Inc. uses heat-moisture treatment to modify particle size (surface average 5–20 µm, volume average 20–100 µm) and denaturation enthalpy, aiming to improve functionality in various foods. Both strategies prioritize texture and protein content over flavor masking or solubility.
Where is the evidence-backed white space for further development of fava bean protein?
Evidence-backed white space exists in combining fava protein with probiotic strains for non-dairy fermented products, as Roquette Freres claims this but only for a limited pH range (3.80–4.40) and protein content (2.5–12.0 g/100g). There is also room for exploring heat-moisture processing parameters beyond the claimed denaturation enthalpy reduction (10–30%) and particle size ratios. No patents address flavor masking or off-note reduction, which is a common challenge for legume proteins. Additionally, no claims cover meat analogs or bakery applications, suggesting potential for diversification. These gaps are based on the limited patent set.